Literature DB >> 31176779

miR-21-5p promotes lung adenocarcinoma progression partially through targeting SET/TAF-Iα.

Jiacheng Zhong1, Xiaohu Ren1, Zhihong Chen1, Hang Zhang1, Li Zhou1, Jianhui Yuan1, Ping Li1, Xiao Chen1, Wei Liu1, Desheng Wu1, Xifei Yang1, Jianjun Liu2.   

Abstract

OBJECTIVE: Although SET(I2PP2A) and miRNAs are reported to play a pivotal role in lung cancer, the underlying mechanisms have remained obscure. To address this issue, we investigated how miRNAs and SET participate in the progression of lung cancer.
METHODS: miRNAs that target SET were predicted from multiple miRNA databases. Three human NSCLC cell lines and two normal lung cell lines were used to evaluate aberrant miRNA and SET expressions. A dual luciferase reporter assay system was employed to verify the interaction between miRNA and SET. Stable miRNA knockdown and SET overexpression in A549 cells were achieved through lentivirus transfection; the corresponding influences on lung cancer progression were also examined.
RESULTS: In this study, A549 was the sole cell line to lack SET/TAF-Iα expression, which was inversely correlated with the up-regulation of miR-21-5p. SET was subsequently revealed as the direct target site of miR-21-5p in A549 cells. The stable miR-21-5p knockdown and SET/TAF-Iα overexpression were shown to markedly enhance the expression of SET/TAF-Iα and to inhibit the migration, invasion, proliferation as well as the in vivo tumorigenicity of A549 cells.
CONCLUSION: We suggest that SET/TAF-Iα might be a tumor suppressing factor regulated by miR-21-5p in lung adenocarcinoma. This might provide a target for lung adenocarcinoma therapy.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lung adenocarcinoma; SET/TAF-Iα; miR-21-5p

Mesh:

Substances:

Year:  2019        PMID: 31176779     DOI: 10.1016/j.lfs.2019.06.014

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  11 in total

1.  Overcoming of Radioresistance in Non-small Cell Lung Cancer by microRNA-320a Through HIF1α-Suppression Mediated Methylation of PTEN.

Authors:  Li-Ming Xu; Hao Yu; Ya-Jing Yuan; Jiao Zhang; Yue Ma; Xu-Chen Cao; Jun Wang; Lu-Jun Zhao; Ping Wang
Journal:  Front Cell Dev Biol       Date:  2020-11-10

2.  miR-30b-5p inhibits cancer progression and enhances cisplatin sensitivity in lung cancer through targeting LRP8.

Authors:  Haitao Qiu; Xiaokang Shen; Bing Chen; Tianming Chen; Guodong Feng; Shilin Chen; Dongjie Feng; Qiaoshu Xu
Journal:  Apoptosis       Date:  2021-03-29       Impact factor: 4.677

3.  Human TAF-Iα promotes oncogenic transformation via enhancement of cell proliferation and suppression of apoptosis.

Authors:  Valentina V Nenasheva; Irina V Makarova; Ekaterina A Stepanenko; Stanislav A Antonov; Ekaterina V Novosadova; Anastasia R Narsullaeva; Larisa V Kozikova; Ekaterina A Polteva; Lyudmila A Sleptsova; Natalya A Shcherbatova; Nella V Khaidarova; Lyudmila E Andreeva; Vyacheslav Z Tarantul
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-05-21       Impact factor: 2.416

4.  miR-196b-5p Promotes Proliferation, Migration and Invasion of Lung Adenocarcinoma Cells via Targeting RSPO2.

Authors:  Qian Xu; Zhenwu Xu
Journal:  Cancer Manag Res       Date:  2020-12-29       Impact factor: 3.989

5.  Identification and evaluation of circulating small extracellular vesicle microRNAs as diagnostic biomarkers for patients with indeterminate pulmonary nodules.

Authors:  Di Zheng; Yuming Zhu; Jiyang Zhang; Wei Zhang; Huizhen Wang; Hao Chen; Chunyan Wu; Jian Ni; Xiaoya Xu; Baoning Nian; Sheng Chen; Beibei Wang; Xiaofang Li; Yanan Zhang; Jiatao Zhang; Wenzhao Zhong; Lei Xiong; Fugen Li; Dadong Zhang; Jianfang Xu; Gening Jiang
Journal:  J Nanobiotechnology       Date:  2022-04-02       Impact factor: 10.435

6.  Hyperoxia Induced Bronchopulmonary Dysplasia-Like Inflammation via miR34a-TNIP2-IL-1β Pathway.

Authors:  Xuwei Tao; Luxia Mo; Lingkong Zeng
Journal:  Front Pediatr       Date:  2022-03-30       Impact factor: 3.418

7.  Prediction of MiR-21-5p in Promoting the Development of Lung Adenocarcinoma via PDZD2 Regulation.

Authors:  Shengjin Cui; Shuang Lou; Weiquan Guo; Shihui Jian; Yunfeng Wu; Xintong Liu; Xi Lan; Xingwang Jia
Journal:  Med Sci Monit       Date:  2020-06-14

8.  MiR-148b suppressed non-small cell lung cancer progression via inhibiting ALCAM through the NF-κB signaling pathway.

Authors:  Zhe Jiang; JingWen Zhang; FuHui Chen; Yajiao Sun
Journal:  Thorac Cancer       Date:  2019-12-27       Impact factor: 3.500

9.  Development and Validation of a Seven-Gene Signature for Predicting the Prognosis of Lung Adenocarcinoma.

Authors:  Yingqing Zhang; Xiaoping Zhang; Xiaodong Lv; Ming Zhang; Xixi Gao; Jialiang Liu; Yufen Xu; Zhixian Fang; Wenyu Chen
Journal:  Biomed Res Int       Date:  2020-08-17       Impact factor: 3.411

10.  Higher content of microcystin-leucine-arginine promotes the survival of intrahepatic cholangiocarcinoma cells via regulating SET resulting in the poorer prognosis of patients.

Authors:  Shen Gu; Wei He; Minghao Yan; Jian He; Qun Zhou; Xiaopeng Yan; Xiao Fu; Jun Chen; Xiaodong Han; Yudong Qiu
Journal:  Cell Prolif       Date:  2020-11-25       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.